Halberd (Halberd) Gross Profit : $0.00 Mil (TTM As of Jul. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Halberd Gross Profit?

Halberd's gross profit for the six months ended in Jul. 2023 was $0.00 Mil. Halberd's gross profit for the trailing twelve months (TTM) ended in Jul. 2023 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Halberd's gross profit for the six months ended in Jul. 2023 was $0.00 Mil. Halberd's Revenue for the six months ended in Jul. 2023 was $0.00 Mil. Therefore, Halberd's Gross Margin % for the quarter that ended in Jul. 2023 was 33.33%.

Halberd had a gross margin of 33.33% for the quarter that ended in Jul. 2023 => Competition eroding margins

During the past 3 years, the highest Gross Margin % of Halberd was 85.71%. The lowest was 33.33%. And the median was 59.52%.

Halberd Gross Profit Historical Data

The historical data trend for Halberd's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Gross Profit Chart

Halberd Annual Data

Trend

Jul08

Jul22

Jul23

Gross Profit

0.01

Halberd Semi-Annual Data
	Jul08	Jul22	Jul23
Gross Profit	0.01	0.01	-

Competitive Comparison of Halberd's Gross Profit

For the Biotechnology subindustry, Halberd's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Halberd's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's Gross Profit distribution charts can be found below:

* The bar in red indicates where Halberd's Gross Profit falls into.

Halberd Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Halberd's Gross Profit for the fiscal year that ended in Jul. 2023 is calculated as

Gross Profit (A: Jul. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	0.003	-	0.002
	=	0.00

Halberd's Gross Profit for the quarter that ended in Jul. 2023 is calculated as

Gross Profit (Q: Jul. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	0.003	-	0.002
	=	0.00

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Gross Profit for the trailing twelve months (TTM) ended in Jul. 2023 was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Halberd's Gross Margin % for the quarter that ended in Jul. 2023 is calculated as

Gross Margin % (Q: Jul. 2023 )	=	Gross Profit (Q: Jul. 2023 )	/	Revenue (Q: Jul. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	0.00	/	0.003
	=	33.33 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Halberd (OTCPK:HALB) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Halberd had a gross margin of 33.33% for the quarter that ended in Jul. 2023 => Competition eroding margins

Halberd Gross Profit Related Terms

Thank you for viewing the detailed overview of Halberd's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Halberd (Halberd) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 25, Jackson Center, PA, USA, 16133

Website

https://www.halberdcorporation.com

Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.

Executives

John Christopher Maddox	director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO	10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist	director, 10 percent owner, officer: CEO, Secretary and Director	24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr.	director	50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas	director	280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236